Higher BDNF Linked to Lower Neuroinflammation Marker in Older Adults
A strong inverse relationship between BDNF and S100B in older adults hints at a neurotrophic-neuroinflammatory balance critical for brain aging.
Summary
Researchers measured two blood-based brain biomarkers — BDNF, which supports neuron survival, and S100B, a marker of neuroinflammation — in 95 community-dwelling adults aged 65 and older in rural Japan. They found a striking inverse relationship: the higher a person's serum BDNF, the lower their S100B. This association held firm after adjusting for age, sex, education, and BMI. Interestingly, neither biomarker correlated with cognitive test scores or depressive symptoms in this relatively healthy sample. The findings suggest that lifestyle or clinical interventions that raise BDNF — such as exercise or certain nutrients — might simultaneously dampen neuroinflammatory signaling, potentially protecting the aging brain. However, the cross-sectional design prevents causal conclusions, and the sample was small and geographically limited.
Detailed Summary
As the global population ages, preserving cognitive function and mental health in older adults has become a pressing public health priority. Two blood-based biomarkers have emerged as important windows into brain health: brain-derived neurotrophic factor (BDNF), which promotes neuron survival and plasticity, and S100 calcium-binding protein B (S100B), which rises during neuroinflammation and glial activation. Understanding how these markers relate to each other and to real-world cognition could guide future interventions.
This cross-sectional study enrolled 95 community-dwelling adults aged 65 or older living in rural Japan. Serum BDNF and S100B were quantified by enzyme-linked immunosorbent assay. Cognitive function was assessed with four validated neuropsychological instruments, and depressive symptoms were also measured. Spearman correlations and multiple regression models — using log-transformed values and controlling for age, sex, education, and BMI — examined associations among all variables.
The headline finding was a robust inverse correlation between BDNF and S100B (β = −0.509, p < 0.0001), which persisted across all adjusted and sensitivity models. In plain terms, older adults with higher BDNF tended to have lower neuroinflammatory signaling, and vice versa. Unexpectedly, neither biomarker correlated significantly with cognitive test performance or depressive symptom scores in this sample.
These results suggest that BDNF and S100B represent two sides of a neurobiological balance — neurotrophic support on one hand and neuroinflammatory activity on the other. Interventions known to elevate BDNF, including aerobic exercise, dietary patterns, and certain supplements, may therefore also reduce S100B-mediated neuroinflammation, offering a dual mechanism for protecting the aging brain.
Several caveats temper these conclusions. The cross-sectional design precludes establishing causality or temporal direction. The sample of 95 participants from one rural region of Japan limits generalizability. Additionally, this summary is based on the abstract only; full methodological details and subgroup analyses are unavailable without access to the complete paper.
Key Findings
- Serum BDNF and S100B were strongly inversely correlated (β = −0.509) in adults aged 65+, independent of age, sex, education, or BMI.
- The BDNF–S100B inverse relationship was consistent across all adjusted regression models and sensitivity analyses.
- Neither BDNF nor S100B levels correlated with cognitive function or depressive symptoms in this community sample.
- Findings suggest interventions that raise BDNF (e.g., exercise) may simultaneously lower neuroinflammatory S100B signaling.
- Results highlight a neurotrophic-neuroinflammatory axis as a measurable blood-based target in aging brain health.
Methodology
Cross-sectional study of 95 community-dwelling adults aged ≥65 in rural Japan. Serum BDNF and S100B were measured by ELISA; cognitive and depressive outcomes were assessed with four instruments. Associations were examined via Spearman correlations and multiple regression on log10-transformed biomarker values, adjusted for age, sex, education, and BMI.
Study Limitations
The cross-sectional design prevents any causal or temporal inference between BDNF, S100B, and brain health outcomes. The sample (n = 95, rural Japan) is small and geographically homogeneous, limiting generalizability. Additionally, this summary is based on the abstract only; full results, subgroup data, and methodological details could not be reviewed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: